A new report from Kaufman Hall examines two potential financial situations for hospitals in 2021 one optimistic, and the other bleak. Hospitals could lose between $53 billion and $122 billion depending on which scenario plays out.
MedCity News
FDA approves Sarepta drug for muscular dystrophy with rare genetic mutation
The FDA decision gives Sarepta Therapeutics its third approved drug for Duchenne muscular dystrophy. The accelerated approval requires the biotech to conduct additional clinical testing to confirm the drug’s benefit.
Shares0
The FDA has approved a Sarepta Therapeutics drug for Duchenne muscular dystrophy, clearing the way for the company to commercialize its third therapy for the rare, muscle-wasting disease.
Thursday’s decision covers patients with a particular genetic mutation that affects an estimated 8% of Duchenne patients. The drug, casimersen, will be marketed under the name Amondys 45.
Trade groups representing U.S. public power and natural gas companies urged President Joe Biden to declare a gas emergency for last week's extreme weather and authorize the secretary of energy to cap the price of gas.
PHC takes notice of financial crisis in public sector universities
National
February 26, 2021
PESHAWAR: The Peshawar High Court (PHC) has taken notice of the financial crises in the public sector universities and directed the government and relevant departments to address the issue at the earliest.
PHC Chief Justice Qaiser Rashid Khan, while hearing a case about the financial crises in KP universities, remarked that some of these institutions were on the verge of closure and even teachers were not receiving salaries.
He asked the government and departments concerned as to why it was happening and who would find a solution to the situation. The chief justice directed the government and the relevant departments to address the issues of these institutions at the earliest for the sake of future generations.
NEW YORK, Feb. 25, 2021 /PRNewswire/ Velocity Acquisition Corp. today announced the closing of its initial public offering of 23,000,000 units at a price of $10.00 per unit, including. | March 3, 2021